We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > XenoGesis

News List

Sygnature Discovery Acquires XenoGesis contractpharma
September 27, 2020
Sygnature Discovery, an integrated discovery and pre-clinical solutions provider, has expanded its DMPK capabilities and expertise with the acquisition of XenoGesis, an independent laboratory-based CRO specializing in pre-clinical DMPK ...
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics europeanpharmaceuticalreview
May 20, 2020
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.
XenoGesis to Move Into BioCity Discovery Building contractpharma
May 22, 2018
XenoGesis will be the next tenant to move into BioCity Nottingham’s state-of-the-art Discovery Building,